ARC in Hemorrhagic Stroke

University of North Carolina (UNC)

Status: Completed

Conditions: Augmented Renal Clearance; Hemorrhagic Stroke

Treatments: Other: No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT02386202

14-1491

Details and patient eligibility

About

To determine the incidence and predictors of augmented renal clearance (ARC) in patients with hemorrhagic stroke.

Enrollment: 80 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adults ≥ 18 years
• Patients with hemorrhagic stroke
• Anticipated length of stay in the neuroscience intensive care unit > 48 hours
• Informed consent provided by the patient or by the patient's designated medical proxy

Exclusion criteria

• Pregnancy
• Patients with pre-existing renal dysfunction (chronic kidney disease stages 3 - 5)
• Patients receiving renal replacement therapy
• Patients with an admission serum creatinine > 1.4 mg/dL
• Patients with non-aneurysmal subarachnoid hemorrhage
• Patients with history of nephrectomy or body mass index < 18 kg/m2

Trial design

80 participants in 1 patient group

Patients with hemorrhagic stroke

Description:

All patients with hemorrhagic stroke admitted to the neurosciences ICU are eligible for study enrollment.

Treatment:

Other: No intervention